Results 11 to 20 of about 68,419 (263)

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study. [PDF]

Trials, 2022
Mackenzie GA, Osei I, Salaudeen R, Secka O, D'Alessandro U, Clarke E, Schmidt-Chanasit J, Licciardi PV, Nguyen C, Greenwood B, Mulholland K.   +10 more
europepmc   +3 more sources

Yellow fever vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2013
Yellow fever (YF) is an acute viral communicable disease transmitted by an arbovirus of the Flavivirus genus. It is primarily a zoonotic disease, especially the monkeys. Worldwide, an estimated 200,000 cases of yellow fever occurred each year, and the case-fatality rate is ~15%.
J. Erin Staples, Thomas P. Monath, Mark D. Gershman, Alan D.T. Barrett   +3 more
  +6 more sources

A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers. [PDF]

Vaccines (Basel)
Fukushima S, Lim CK, Hamada A.
europepmc   +3 more sources

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. [PDF]

Nat Commun
Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster EM, Dobler G, Hoelscher M, Kümmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S.   +19 more
europepmc   +3 more sources

Yellow fever vaccination before and during the covid-19 pandemic in Brazil

Revista de Saúde Pública, 2022
OBJECTIVE To analyze the number of yellow fever vaccine doses administered before and during the covid-19 pandemic in Brazil. METHODS This is an ecological, time series study based on data from the National Immunization Program.
Tércia Moreira Ribeiro da Silva, Ana Carolina Micheletti Gomide Nogueira de Sá, Elton Junio Sady Prates, Daiana Elias Rodrigues, Thales Philipe Rodrigues da Silva, Fernanda Penido Matozinhos, Ed Wilson Rodrigues Vieira   +6 more
doaj   +1 more source

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Human Vaccines & Immunotherapeutics, 2022
Despite the existence of a highly efficient yellow fever vaccine, yellow fever reemergence throughout Africa and the Americas has put 900 million people in 47 countries at risk of contracting the disease.
Gerardo Montalvo Zurbia-Flores, Christine S Rollier, Arturo Reyes-Sandoval   +2 more
doaj   +1 more source

Characterization of Yellow Fever Suspected Cases and Confirmed Outbreaks in a Southwest State, Nigeria, 2021 [PDF]

Journal of Health Sciences and Surveillance System, 2022
Background: Yellow fever (YF) is an acute viral hemorrhagic fever caused by the yellow fever virus and transmitted by Aedes mosquito species. Despite the availability of a very effective vaccine, yellow fever virus (YFV) remains a public health threat ...
Itse Olaoye, Akinola Fatiregun, Adewale M. Adejugbagbe, Modupeola Dosumu, Ekun Opeyemi, Zubairu Mahmud, David Adeleke, Tsemaye Jacdonmi, Aladesawe Adesokeji, Famokun Gboyega, Abiona Samuel   +10 more
doaj   +1 more source

Invasive aspergillosis complication in yellow fever vaccine induced viscerotropic disease. [PDF]

Med Mycol Case Rep, 2020
Breda GL, Domino NR, de Noronha L, Duarte Dos Santos CN, Zanluca C, Kruger RS, Queiroz-Telles F, Raboni SM.   +7 more
europepmc   +2 more sources

Yellow Fever Vaccine

Nursing times, 2006
europepmc   +4 more sources

Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009. [PDF]

PLoS Neglected Tropical Diseases, 2014
Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano, Zouraide Guerra Antunes Costa, Daniel Garkauskas Ramos, Maria Auxiliadora Andrade, Valéria de Sá Jayme, Marco Antônio Barreto de Almeida, Kátia Campomar Vettorello, Melissa Mascheretti, Brendan Flannery   +8 more
doaj   +1 more source